Cytelytics: Smarter Monitoring for Confident Trial Oversight
Site visit and SDV patterns that derail trials — Cytelytics detects them before regulators do.
See More. Act Sooner. Strengthen Oversight.
Traditional on-site monitoring and 100% SDV account for up to 30% of clinical trial costs, yet they are not designed to detect statistical anomalies within or across patients, sites, or studies. As the backbone of a modern risk-based quality management (RBQM) strategy, Cytelytics delivers real-time insight into your data — flagging risks, surfacing trends, and preventing trial disruptions. It equips your team with precision-targeted oversight and helps you cut waste without compromising quality.
Cytelytics provides a structured and data-driven approach to Central Statistical Monitoring, delivering an Overall Index Report along with Rate, Query, Timing, Categorical, and Continuous Analyses to help detect emerging risks and optimize trial oversight.
Proactive Risk Mitigation
Detect emerging risks, enabling timely intervention and improved study oversight.
Cut Oversight Costs
Reduce expensive, low-impact SDV activities and redirect resources where they are needed.
Enhanced Data Quality
Ensure cleaner, more reliable data through early identification of anomalies and inconsistencies.
Comprehensive Monitoring
Integrate multiple data sources for a holistic approach to risk-based monitoring.
Built to Strengthen Every Phase of Your Study
Cytelytics doesn’t just plug in — it embeds into your clinical study process to drive better outcomes from day one. By structuring key steps across the phases, it enables study teams to proactively identify risks and enhance monitoring efficiency.
Claim your free 30-minute strategy session
Book a free, no-obligation strategy session with a Cytel expert to get advice on how to improve your drug's probability of success and plot a clearer route to market.
